Skip to content

Evaluation of long term intake of test supplement on safety -open labeled study-

Evaluation of long term intake of test supplement on safety -open labeled study- - Safety of long term intake of test supplement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000037244
Enrollment
20
Registered
2019-07-15
Start date
2019-07-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Intake of test supplement for 12 consecutive weeks

Sponsors

TTC Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Male and female whose age is between 20 and 64 years old

Exclusion criteria

Exclusion criteria: (1) Subjects who have diabetes, liver disease, kidney disease, heart disease, diseases that affect the secretion of adrenocortical hormones, other metabolic diseases, or subjects who have a history of such diseases (2) Subjects who have diseases requiring continuous medication, or serious medical history who needed medication (3) Subjects who routinely use some medicine (including over-the-counter drug) (4) Subjects who are judged as unsuitable for the study based on the results of clinical laboratory test or cardiopulmonary function (5) Subjects with allergies to the test food in this study (6) Females who are known or suspected to be pregnant, breastfeeding or desire to become pregnant during the trial period (7) Subjects who have participated in other clinical study within the past month prior (8) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (9) Subjects who are judged as unsuitable for the study based on the results of clinical laboratory test or physical examination (10) Subjects who are judged as unsuitable for the study by the investigator for other reason

Design outcomes

Primary

MeasureTime frame
Hematologic test Blood biochemistry test Urine analysis Blood pressure/pulsation Weight/body mass index Doctor's question Adverse event

Countries

Japan

Contacts

Public ContactYoshimi Bansho

TTC Co., Ltd. Clinical Research Planning Department

y.bansho@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026